Literature DB >> 13995020

Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution.

N TYGSTRUP.   

Abstract

Entities:  

Keywords:  GALACTOSE; LIVER

Mesh：

Substances：

Year:  1963        PMID： 13995020     DOI： 10.1111/j.1748-1716.1963.tb02638.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN： 0001-6772


× No keyword cloud information.
  24 in total

1.  Effect of portal-systemic anastomosis on renal haemodynamics in cirrhosis.

Authors:  H Ring-Larsen; B Hesse; B Stigsby
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

Review 2.  Clinical pharmacokinetics in patients with liver disease.

Authors:  A J McLean; D J Morgan
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

3.  Low-dose interferon in chronic hepatitis non-A/non-B: effects on quantitative liver function and structure in a randomized, controlled multicenter trial.

Authors:  J Reichen; M Solioz; H Bühler; J J Gonvers; M Knoblauch; D Lavanchy; P J Malé; B Meyer; M Schmid; L Bianchi
Journal:  Clin Investig       Date:  1993-11

4.  Hepatic Clearance and Lm of Galactose in Normal and Cirrhotic Subjects.

Authors:  C Dal Palù; P Spandri; R Zuin
Journal:  Postgrad Med J       Date:  1965-05       Impact factor: 2.401

5.  [Hepatic galactose elimination lapacity in chronic renal insufficiency (author's transl)].

Authors:  H Wernze; F Wagner
Journal:  Klin Wochenschr       Date:  1973-09-15

6.  Mesocaval and distal splenorenal shunts: effect on hepatic function, hepatic hemodynamics, and portal systemic encephalopathy.

Authors:  R Herz; H J Halbfass; M Rössle; D Waldmann; W Gerok
Journal:  Klin Wochenschr       Date:  1985-05-02

7.  Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.

Authors:  J Reichen; B Egger; N Ohara; T B Zeltner; T Zysset; A Zimmermann
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 8.  Quantitative PET of liver functions.

Authors:  Susanne Keiding; Michael Sørensen; Kim Frisch; Lars C Gormsen; Ole Lajord Munk
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

9.  Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease.

Authors:  S Krähenbühl; P Grass; A Surve; K Kutz; J Reichen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.

Authors:  C Merkel; D Sacerdoti; G F Finucci; R Zuin; G Bazzerla; M Bolognesi; A Gatta
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.